Vitamin D and Vitamin D binding protein: the inseparable duo in COVID-19.

Speeckaert, M M; Speeckaert, R; Delanghe, J R

Speeckaert, M M; Speeckaert, R; Delanghe, J R.

Speeckaert MM; Department of Nephrology, Ghent University Hospital, Corneel Heymanslaan 10 9000, Ghent, Belgium. Marijn.Speeckaert@ugent.be.
Speeckaert R; Research Foundation-Flanders (FWO), Brussels, Belgium. Marijn.Speeckaert@ugent.be.
Delanghe JR; Research Foundation-Flanders (FWO), Brussels, Belgium.

J Endocrinol Invest ; 44(10): 2323-2324, 2021 Oct.

Article in English | MEDLINE | ID: covidwho-1174048

Subject(s)

COVID-19; Macrophage-Activating Factors/immunology; Vitamin D-Binding Protein/immunology; Vitamin D; COVID-19/immunology; COVID-19/mortality; Humans; Immunologic Factors/blood; Immunologic Factors/metabolism; Mortality; Polymorphism, Single Nucleotide; Prognosis; Protective Factors; SARS-CoV-2; Vitamin D/blood; Vitamin D/metabolism; Vitamin D-Binding Protein/genetics; Vitamin D-Binding Protein/metabolism

Keywords

COVID-19; Polymorphism; Vitamin D binding protein; Vitamin D deficiency

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitamin D / Vitamin D-Binding Protein / Macrophage-Activating Factors / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Endocrinol Invest Year: 2021 Document Type: Article Affiliation country: S40618-021-01573-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google